Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 4/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | CFTR | P13569 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.32 |
| ▸ | TGM2 | P21980 | 1/20 | 0.31 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.31 |
| ▸ | NPY4R | P50391 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19655013 | 0.89 | ABCB1 (0.36) | FPR2ABCB1USP2CFTRPAX8 | |
| SCHEMBL19655015 | 0.87 | FPR2 (0.39) | FPR2ABCB1USP2CFTRPAX8 | |
| SCHEMBL19655018 | 0.85 | ABCB1 (0.34) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL17863900 | 0.84 | ABCB1 (0.34) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL19495011 | 0.79 | ABCB1 (0.35) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL26472325 | 0.79 | FTO (0.42) | FPR2ABCB1USP2CFTRPAX8 | |
| SCHEMBL19495000 | 0.78 | SCN1A (0.36) | FPR2ABCB1USP2CFTRPAX8 | |
| SCHEMBL19494775 | 0.77 | ABCB1 (0.42) | FPR2ABCB1USP2CFTRPAX8 | |
| SCHEMBL18854257 | 0.77 | ABCB1 (0.36) | FPR2ABCB1USP2CFTRPAX8 | |
| SCHEMBL19655007 | 0.76 | ABCB1 (0.40) | FPR2ABCB1USP2CFTRPAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170342031-A1 | QUENCHER | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170342031-A1 | QUENCHER | AHR, GFER, AKR1A1 | FPR2 83/4885ABCB1 2678/4885USP2 3122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.